Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Increases By 392.3%

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the recipient of a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 172,800 shares, a growth of 392.3% from the May 31st total of 35,100 shares. Based on an average daily volume of 51 shares, the days-to-cover ratio is currently 3,388.2 days.

Ascentage Pharma Group International Stock Performance

ASPHF stock opened at $4.53 on Friday. The business has a 50-day moving average price of $6.17 and a 200 day moving average price of $7.67. Ascentage Pharma Group International has a 1-year low of $4.53 and a 1-year high of $5.05.

About Ascentage Pharma Group International

Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.

Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.